JEFFREY A BERMAN
Psychologist in Cambridge, MA
License number
Massachusetts 3524
Issued Date
Jun 15, 1984
Expiration Date
Jun 30, 2002
Type
Psychologist
Address
Address
Cambridge, MA 02142
Organization information
See more information about JEFFREY A BERMAN at bizstanding.comJEFFREY BERMAN FOUNDATION
10 Rogers St #1018, Cambridge, MA 02142
Registration:
Oct 5, 2007
Phone:
(617) 494-1967 (Phone)
State ID:
000961911
Business type:
Foreign Corporation
Entity State:
DE
Secretarys:
Jeffrey A Berman (President), 10 Rogers St #1018, Cambridge, MA 02142 (Physical),Beth C Luchner (Secretary), 10 Rogers St #1018, Cambridge, MA 02142 (Physical)
Agent:
Jeffrey Berman,10 Rogers St #418, Cambridge, MA 02142 (Physical)
Categories:
Community & Civic Organizations
Professional information
Diagnostic And Prognostic Methods For Lung Disorders Using Gene Expression Profiles From Nose Epithelial Cells
US Patent:
2011021, Sep 8, 2011
Filed:
Nov 5, 2010
Appl. No.:
12/940840
Inventors:
Jerome S. Brody - Newton MA, US
Avrum Spira - Newton MA, US
Jeffrey S. Berman - Cambridge MA, US
Anthony W. O'Regan - Galway, IE
Avrum Spira - Newton MA, US
Jeffrey S. Berman - Cambridge MA, US
Anthony W. O'Regan - Galway, IE
International Classification:
C12Q 1/68
US Classification:
435 614
Abstract:
The present invention provides methods for diagnosis and prognosis of lung cancer using expression analysis of one or more groups of genes, and a combination of expression analysis from a nasal epithelial cell sample. The methods of the invention provide far less invasive method with a superior detection accuracy for lung cancer when compared to any other currently available method for lung cancer diagnostic or prognosis. The invention also provides methods of diagnosis and prognosis of other lung diseases, such as lung cancer.
Diagnostic And Prognostic Methods For Lung Disorders Using Gene Expression Profiles From Nose Epithelial Cells
US Patent:
2012019, Jul 26, 2012
Filed:
Dec 12, 2011
Appl. No.:
13/323655
Inventors:
Jerome S. Brody - Newton MA, US
Avrum Spira - Newton MA, US
Jeffrey S. Berman - Cambridge MA, US
Anthony W. O'Regan - Galway, IE
Avrum Spira - Newton MA, US
Jeffrey S. Berman - Cambridge MA, US
Anthony W. O'Regan - Galway, IE
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
The present invention provides methods for diagnosis and prognosis of lung cancer using expression analysis of one or more groups of genes, and a combination of expression analysis from a nasal epithelial cell sample. The methods of the invention provide far less invasive method with a superior detection accuracy for lung cancer when compared to any other currently available method for lung cancer diagnostic or prognosis. The invention also provides methods of diagnosis and prognosis of other lung diseases, such as lung cancer.
Diagnostic And Prognostic Methods For Lung Disorders Using Gene Expression Profiles From Nose Epithelial Cells
US Patent:
2009006, Mar 5, 2009
Filed:
Mar 8, 2007
Appl. No.:
12/282320
Inventors:
Jerome S. Brody - Newton MA, US
Avrum Spira - Newton MA, US
Jeffrey S. Berman - Cambridge MA, US
Anthony W. O'Regan - Galway, IE
Avrum Spira - Newton MA, US
Jeffrey S. Berman - Cambridge MA, US
Anthony W. O'Regan - Galway, IE
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides methods for diagnosis and prognosis of lung cancer using expression analysis of one or more groups of genes, and a combination of expression analysis from a nasal epithelial cell sample. The methods of the invention provide far less invasive method with a superior detection accuracy for lung cancer when compared to any other currently available method for lung cancer diagnostic or prognosis. The invention also provides methods of diagnosis and prognosis of other lung diseases, such as lung cancer.